Evaluation of low-pass genome sequencing in polygenic risk score calculation for Parkinson’s disease

BACKGROUND: Low-pass sequencing (LPS) has been extensively investigated for applicability to various genetic studies due to its advantages over genotype array data including cost-effectiveness. Predicting the risk of complex diseases such as Parkinson’s disease (PD) using polygenic risk score (PRS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sungjae, Shin, Jong-Yeon, Kwon, Nak-Jung, Kim, Chang-Uk, Kim, Changhoon, Lee, Chong Sik, Seo, Jeong-Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403377/
https://www.ncbi.nlm.nih.gov/pubmed/34454617
http://dx.doi.org/10.1186/s40246-021-00357-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403377/
https://www.ncbi.nlm.nih.gov/pubmed/34454617
http://dx.doi.org/10.1186/s40246-021-00357-w

Ejemplares similares